In addition to comprehensive testing and evaluations for prevalent peripheral neuropathies, we offer a full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions. Expertly curated for phenotype-specific conditions, our testing uses targeted capture techniques, laboratory-developed confirmation criteria, and unique reporting methods.
OTHER TESTING FOR inherited peripheral neuropathy Test menu
Key testing
Key testing
Key testing
Highlights
Justin Fugelsang and Zach Pedowitz have never met. Yet both young men were diagnosed with a rare form of Charcot-Marie-Tooth disease, called sorbitol dehydrogenase (SORD) deficiency, and both found clarity through Mayo Clinic Laboratories' innovative SORD testing. Their journeys inspire resilience, as Justin has channeled his emotions into guitar playing, and Zach has embraced educational leadership.
Matthew J. Schultz, Ph.D., and Amy L. White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.
Key testing
Key testing